<a href='https://email.asam.org/t/t-i-gkhlkld-l-p/'>States With Substantial Increases In Buprenorphine Uptake Did So With Increased Medicaid Prescribing, 2018–24</a>
Health Affairs
Multiple federal policy changes since 2018 intended to increase buprenorphine prescribing in response to a persistent treatment gap for opioid use disorder (OUD) in the US. Anticipated national increases did not occur, but highly variable state-level trends provide important insights. This study used IQVIA data to examine all-payer and per payer prescribing across states during the period 2018–24.  Researchers found that highly disparate state-level changes suggest that federal policy impacts were mediated by state-specific factors. Medicaid’s key role in driving overall prescribing highlights the public health urgency of maintaining expansions and sustaining enrollment for the single adult population. 
 
<a href='https://email.asam.org/t/t-e-gkhlkld-l-ti/'>Read this issue of the ASAM Weekly</a>
<a href='https://email.asam.org/t/ViewEmail/t/409ED172E9728DA22540EF23F30FEDED?alternativeLink=True'>Subscribe to the ASAM Weekly</a>
<a href='https://email.asam.org/t/ViewEmail/t/7B8FCC540811FB9A2540EF23F30FEDED/C67FD2F38AC4859C/?tx=0&previewAll=1&print=1&source=PrintPreview&context=BE1559E32AC7F640D744A813E2B67A32'>Visit ASAM</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Lead: States With Substantial Increases In Buprenorphine Uptake Did So With Increased Medicaid Prescribing, 2018–24

This Week in Addiction Medicine from ASAM

AI Chapters

AI Insights

Reviews